Literature DB >> 12840187

High dietary fat promotes syndrome X in nonobese rats.

Kathleen V Axen1, Aphrodite Dikeakos, Anthony Sclafani.   

Abstract

High fat, low carbohydrate diets are popularly advocated for weight loss and improvement in metabolic Syndrome X, a constellation of risk factors for type 2 diabetes mellitus and cardiovascular disease. The effects of an energy-restricted (to prevent weight gain in excess of normal growth) high fat (60% of energy), low carbohydrate (15%) diet were assessed in both lean rats and in rats previously rendered obese through ad libitum consumption of the same high fat diet. In obese rats, restriction of intake failed to improve impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia, although it lowered visceral fat mass, liver lipid content and in vitro insulin hypersecretion compared with rats continuing to consume the high fat diet ad libitum. In lean rats, restricted intake of the high fat diet impaired glucose tolerance and increased visceral fat mass and liver lipid content. These findings support the conclusion that, in the absence of weight loss, a high fat, low carbohydrate diet not only may be ineffective in decreasing risk factors for cardiovascular disease and type 2 diabetes but may promote the development of disease in previously lower risk, nonobese individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12840187     DOI: 10.1093/jn/133.7.2244

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  23 in total

Review 1.  Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Metin Basaranoglu; Serra Kayacetin; Nevin Yilmaz; Ertugrul Kayacetin; Orhan Tarcin; Abdullah Sonsuz
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women.

Authors:  Lu Wang; JoAnn E Manson; Susanne Rautiainen; J Michael Gaziano; Julie E Buring; Michael Y Tsai; Howard D Sesso
Journal:  Eur J Nutr       Date:  2015-03-29       Impact factor: 5.614

3.  Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Gianluca Miglio; Chiara Tomasinelli; Giuseppe Boccuzzi; Christoph Thiemermann; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

Review 4.  Insulin, cognition, and dementia.

Authors:  Brenna Cholerton; Laura D Baker; Suzanne Craft
Journal:  Eur J Pharmacol       Date:  2013-09-23       Impact factor: 4.432

5.  A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L: -carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet.

Authors:  Yun Jung Kim; Keun-Young Kim; Min Sun Kim; Jin Hee Lee; Kang Pyo Lee; Taesun Park
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

Review 6.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.

Authors:  Suzanne Craft
Journal:  Arch Neurol       Date:  2009-03

Review 7.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Authors:  Olivier Thibault; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Philip W Landfield; Nada M Porter
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

Review 8.  Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.

Authors:  Renata Micha; Dariush Mozaffarian
Journal:  Nat Rev Endocrinol       Date:  2009-04-28       Impact factor: 43.330

Review 9.  Trans-fatty acids and nonlipid risk factors.

Authors:  Sarah K Wallace; Dariush Mozaffarian
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

10.  Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.

Authors:  Alexander A Moghadam; Timothy H Moran; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.